- Home
- LPCN vs ELWS Comparison
LPCN vs ELWS Comparison
Compare LPCN & ELWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- ELWS
- Stock Information
- Founded
- LPCN 1997
- ELWS 2018
- Country
- LPCN United States
- ELWS Japan
- Employees
- LPCN N/A
- ELWS N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- ELWS
- Sector
- LPCN Health Care
- ELWS
- Exchange
- LPCN Nasdaq
- ELWS Nasdaq
- Market Cap
- LPCN 13.8M
- ELWS 12.9M
- IPO Year
- LPCN N/A
- ELWS 2023
- Fundamental
- Price
- LPCN $3.18
- ELWS $5.80
- Analyst Decision
- LPCN Strong Buy
- ELWS
- Analyst Count
- LPCN 1
- ELWS 0
- Target Price
- LPCN $7.00
- ELWS N/A
- AVG Volume (30 Days)
- LPCN 54.7K
- ELWS 61.0K
- Earning Date
- LPCN 11-06-2025
- ELWS 09-30-2025
- Dividend Yield
- LPCN N/A
- ELWS N/A
- EPS Growth
- LPCN N/A
- ELWS N/A
- EPS
- LPCN N/A
- ELWS N/A
- Revenue
- LPCN $4,322,693.00
- ELWS $3,083,071.00
- Revenue This Year
- LPCN N/A
- ELWS N/A
- Revenue Next Year
- LPCN N/A
- ELWS N/A
- P/E Ratio
- LPCN N/A
- ELWS N/A
- Revenue Growth
- LPCN N/A
- ELWS 145.52
- 52 Week Low
- LPCN $2.52
- ELWS $1.64
- 52 Week High
- LPCN $5.50
- ELWS $10.50
- Technical
- Relative Strength Index (RSI)
- LPCN 61.21
- ELWS 64.04
- Support Level
- LPCN $3.07
- ELWS $5.41
- Resistance Level
- LPCN $3.32
- ELWS $6.06
- Average True Range (ATR)
- LPCN 0.20
- ELWS 0.52
- MACD
- LPCN 0.06
- ELWS 0.07
- Stochastic Oscillator
- LPCN 65.82
- ELWS 92.62
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About ELWS Earlyworks Co. Ltd.
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.